Toggle light / dark theme

How Neuroscience Backs Baars’ Global Workspace Theory

Exploring the Global Workspace Theory: Consciousness Unveiled. Join us as we unravel Bernard Baars’ groundbreaking Global Workspace Theory (GWT) and discover how our brain functions like a theater, spotlighting conscious experiences.

00:00:00 Introduction to Global Workspace Theory.
00:00:34 Global Broadcasting.
00:01:08 Evidence from Brain Imaging and EEG Studies.
00:01:35 Common Mechanism for Conscious Access.
00:02:21 Intracranial EEG Study by Gaillard and Colleagues.
00:02:56 Brain Activity Overdrive.
00:03:56 Neuronal Synchrony and Binocular Rivalry.
00:04:13 Rhythm of Awareness.
00:05:03 Dynamic Synchrony and Global Accessibility.
00:05:19 On-Air Sign for the Brain.
00:05:35 Long-Distance Coordination and Global Coherence.
00:06:04 The Brain Orchestra.
00:06:20 Global Workspace and Clinical Neurology.
00:06:49 Disrupting Global Connectivity.
00:07:22 Frontal Lobe Lesions and Blindsight.
00:08:01 Widespread Disconnection and Fading of Consciousness.
00:08:57 Recovery from Disorders of Consciousness.
00:09:16 Temporary Inactivation with TMS
00:10:12 Interrupting Broadcasting Hubs.
00:10:35 Restoring Connectivity and Consciousness.
00:11:26 Jump-Starting Thalamo-Cortical Circuits.
00:11:43 Re-Engaging the Global Workspace.
00:11:58 The Brain’s Internal News Feed.
00:12:31 Broadcasting and Subjective Experience.

Panpsychism and Explaining Consciousness — TED Talk — David Chalmers

Our consciousness is a fundamental aspect of our existence, says philosopher David Chalmers: “There’s nothing we know about more directly… but at the same time it’s the most mysterious phenomenon in the universe.” He shares some ways to think about the movie playing in our heads.

Brain Volumes After Hypertensive Pregnancy and Postpartum Blood Pressure Management: A POP-HT Randomized Clinical Trial Imaging Substudy

In a randomized clinical trial of women with prior HypertensivePregnancy, physician-optimized postpartum blood pressure self-management was associated with larger white matter brain volumes at 9 months compared with usual care.

Women with a history of preeclampsia receiving usual care had smaller volumes in subcortical regions (putamen, accumbens, pallidum) than those with gestational hypertension, differences that were not observed in the intervention group.


This randomized clinical trial indicates that a postpartum blood pressure management intervention after hypertensive disorders of pregnancy may be associated with favorable brain structure during the first year post partum. The intervention was linked to larger white matter volumes across women with hypertensive pregnancy (gestational hypertension and preeclampsia). In addition, women with a history of preeclampsia in the usual care arm showed smaller subcortical brain volumes at 6 to 9 months post partum than those with gestational hypertension; these differences were not evident among women in the intervention arm.

Both women with preeclampsia and gestational hypertension experience high blood pressure during pregnancy that frequently persists post partum.28 Lower white matter integrity has been reported from the peripartum period into later life.3,12,29 Hypertension-related white matter injury30,31 is associated with slower processing speed, executive dysfunction, and memory impairment.31 Although cognitive impact may not be obvious in the early postpartum period, white matter changes predict later cognitive decline and dementia,32 and converging longitudinal evidence suggests that reductions in white matter volume and integrity track cognitive decline, supporting the interpretation that better-preserved white matter is beneficial.33

Whether postpartum white matter changes are preventable or reversible had not been investigated. In this randomized clinical trial, a short-term blood pressure control intervention was associated with larger brain volumes several months later, when most participants were no longer taking antihypertensive medication. This is consistent with the postpartum period as a critical window for pregnancy-associated brain volume and blood pressure changes. Because baseline brain MRIs were not acquired, we cannot distinguish recovery of pregnancy-related changes from a slower postpregnancy decline relative to usual care.

A common biomarker of schizophrenia and bipolar disorder revealed

For decades, schizophrenia and bipolar disorder (BD) were treated as distinct and unrelated psychiatric disorders. Schizophrenia is a psychiatric disorder characterized by altered thinking and emotional patterns, hallucinations, false or irrational beliefs (i.e., delusions), cognitive deficits, and disorganized speech. BD, on the other hand, is marked by extreme mood swings, ranging between periods of high-energy (i.e., mania or hypomania) and depressive episodes.

While the symptoms of schizophrenia and BD are markedly different, many patients diagnosed with either of these conditions experience psychosis at least once in their lifetime. Psychosis is a mental state that causes people to lose touch with reality, experiencing hallucinations, delusions, disorganized speech, and irrational thinking patterns.

More recently, studies found that patients diagnosed with schizophrenia and BD sometimes share other overlapping symptoms, as well as common patterns in their genes and brain organization. This inspired the idea that these disorders are part of a shared psychosis spectrum, which would explain their common features and characteristics.

A spatial and projection-based transcriptomic atlas of paraventricular hypothalamic cell types

Li et al. present a spatial transcriptomic atlas of the mouse paraventricular hypothalamus (PVH) and provide molecular markers for parabrachial-and spinal cord-projecting PVH populations. They further show that Brs3-expressing PVH neurons regulate satiety, as they co-express Mc4r, cause weight gain when silenced, and reduce food intake via parabrachial projections.

Brain inspired machines are better at math than expected

Neuromorphic computers modeled after the human brain can now solve the complex equations behind physics simulations — something once thought possible only with energy-hungry supercomputers. The breakthrough could lead to powerful, low-energy supercomputers while revealing new secrets about how our brains process information.

Processing Speed Impairment in Schizophrenia: An Updated Systematic Review and Meta-Analysis

Meta-analysis of 115 studies evaluating cognitive function in people with Schizophrenia confirms that processing speed, especially as measured by symbol coding tasks, remains among the most impaired cognitive domains compared to controls.

This impairment was reliably more severe than that observed in most other tested cognitive domains, suggesting processing speed may be central to broader cognitive deficits in this population and may relate to altered brain connectivity.


This meta-analysis provides an updated review of the evidence for a central processing speed impairment in people with schizophrenia.

C9orf72 in myeloid cells prevents an inflammatory response to microbial glycogen

Factors that promote inflammation in C9ORF72 mutation carriers with amyotrophic lateral sclerosis (ALS) or frontotemporal dementia (FTD) have remained elusive. McCourt et al. identified pro-inflammatory forms of glycogen in gut contents of people with ALS/FTD and demonstrate that targeting glycogen in a C9orf72 mouse model extends lifespan and reduces neuroinflammation.

Blood-based tests show strong promise for dementia diagnosis—but population diversity matters

In a study published today, Friday, February 13, 2026, in the journal Nature Aging, researchers show that blood-based biomarkers can support accurate dementia diagnosis across diverse populations when integrated with cognitive and neuroimaging measures. Blood-based biomarkers are emerging as one of the most promising advances for the global diagnosis of dementia, including Alzheimer’s disease and frontotemporal lobar degeneration. These tests offer a more accessible, scalable, and cost-effective alternative to traditional diagnostic tools such as brain imaging or cerebrospinal fluid analysis.

However, most blood-based biomarkers have been developed and validated primarily in relatively homogeneous populations. Genetic background, overall physical health, and environmental and social exposures can substantially influence biomarker levels, raising concerns about how well these tests perform across diverse populations worldwide.

/* */